Trial Profile
Phase I study of HM 12525A in patients with type 2 diabetes mellitus
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 28 May 2014
Price :
$35
*
At a glance
- Drugs Efinopegdutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- 28 May 2014 New trial record
- 16 May 2014 This trial received approval in Germany in April 2014, according to a Hanmi Pharmaceuticals media release.